Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Growth In 2026: Market Size, Key Drivers And Future Outlook
Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Expansion Outlook: What Revenue Opportunities Are Ahead?
The artificial intelligence (AI)-driven hospital readmission predictor market has seen substantial growth in recent years. This market is projected to expand from $1.92 billion in 2025 to $2.42 billion in 2026, achieving a compound annual growth rate (CAGR) of 26.2%. Historically, this expansion has been driven by several factors including the increasing adoption of AI in healthcare, a growing demand to reduce hospital readmissions, the rising availability of electronic health records, the broader use of predictive analytics, and an increasing focus on patient outcomes.
The market for artificial intelligence (AI)-driven hospital readmission predictors is projected to experience substantial growth in the coming years. This market is anticipated to reach $6.09 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 25.9%. Key factors contributing to this expansion during the forecast period include increased investments in healthcare information technology infrastructure, enhanced integration of clinical decision support systems, wider adoption of cloud-based analytics platforms, the broadening of remote patient monitoring tools, and a heightened focus on value-based care models. Significant trends observed over the forecast period encompass technological advancements in machine learning models, breakthroughs in real-time patient monitoring, ongoing research and development in natural language processing, the creation of explainable AI specifically for healthcare applications, and improvements in interoperable healthcare IT systems.
Get A Free Sample Report With In-Depth Market Insights:
Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Development Factors: What’s Supporting Demand?
The rising occurrence of chronic conditions is anticipated to fuel expansion in the artificial intelligence (AI)-driven hospital readmission predictor market. These are enduring medical ailments, including diabetes, heart disease, and arthritis, that typically advance gradually and necessitate continuous healthcare and lifestyle adjustments to manage indicators and avert adverse events. Their escalation is predominantly linked to detrimental lifestyle choices such as inadequate nutrition, lack of physical activity, and tobacco use, contributing to a higher likelihood of conditions like diabetes, heart disease, and obesity. Artificial intelligence (AI)-driven hospital readmission predictors assist in managing chronic illnesses by examining patient information to pinpoint individuals prone to re-hospitalization. These tools enhance patient results through facilitating early interventions, tailored care strategies, and prompt follow-up, thereby preventing complications and shortening hospital durations. For example, data from June 2024, released by the National Health Service, a UK government department, showed that 3,615,330 individuals registered with a general practitioner (GP) had a diagnosis of non-diabetic hyperglycemia or pre-diabetes (a state with elevated blood sugar, insufficient for a diabetes classification) in 2023. This represented an 18% rise from 3,065,825 cases recorded in 2022. Consequently, the expanding incidence of chronic diseases is fueling the development of the artificial intelligence (AI)-driven hospital readmission predictor market.
Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Segment Outlook: Which Categories Are Growing Fastest?
The artificial intelligence (AI)-driven hospital readmission predictor market covered in this report is segmented –
1) By Component: Software, Hardware, Services
2) By Deployment Mode: On-Premises, Cloud
3) By Application: Patient Risk Assessment, Care Management, Clinical Decision Support, Population Health Management, Other Applications
4) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Software: Electronic Health Record Integration, Predictive Analytics Platforms, Risk Scoring Systems, Clinical Decision Support Tools
2) By Hardware: Servers, Sensors, Monitoring Devices, Data Storage Devices
3) By Services: Data Analytics Services, Predictive Modeling Services, Integration And Deployment Services, Training And Support Services, Monitoring And Reporting Services
Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Transformation Trends: What Innovations Are Driving Change?
Leading companies in the artificial intelligence (AI)-driven hospital readmission predictor market are concentrating on developing advanced solutions, such as sophisticated predictive modeling, to pinpoint high-risk patients, enable early interventions, and optimize care following discharge. Advanced predictive modeling entails utilizing complex statistical algorithms and machine learning techniques on historical and real-time data to uncover intricate patterns and generate highly accurate forecasts of future outcomes. For instance, in July 2025, Innovaccer Inc., a US-based healthcare AI company, unveiled its AI-Powered Readmissions Management Solution, which integrates advanced predictive modeling to identify avoidable readmissions across Medicare, Medicaid, and uninsured populations. The platform also provides unified 360-degree patient views, agentic AI tools like Care Management Copilot and Pre-Call Coordinator Agent for workflow automation, and benchmark intelligence to aid proactive intervention planning. This solution assists healthcare providers in reducing readmission rates, improving resource allocation, and enhancing overall patient outcomes.
Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Competitive Landscape: Who Leads The Industry?
Major companies operating in the artificial intelligence (AI)-driven hospital readmission predictor market are Oracle Corporation, Siemens Healthineers AG, Cognizant Technology Solutions Corp., Epic Systems Corporation, SAS Institute Inc., Veradigm Inc., Merative LLP, Health Catalyst Inc., Lumeris Inc., Innovaccer Inc., Optum Inc., H2O.ai Inc., Healthfirst Inc., Qventus Inc., Lightbeam Health Solutions Inc., HealthEC LLC, Collective Medical Technologies Inc., CarePredict Inc., HBI Solutions Inc., CloudMedx
View The Full Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Report:
Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Geographic Landscape: Which Region Leads Industry Growth?
North America was the largest region in the artificial intelligence (AI)-driven hospital readmission predictor market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-driven hospital readmission predictor market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
